Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-06-03 | Dr. Nabel’s broad experience and expertise within the pharmaceutical and biotech industries, as well as his history of leadership within the National Institutes of Health, will provide the Board with valuable insights into many aspects of our business. |
| 2023-05-01 | Dr. Nabel’s broad experience and expertise within the pharmaceutical and biotech industries, as well as his history of leadership within the National Institutes of Health, will provide the Board with valuable insights into many aspects of our business, including with respect to our science based and research and development programs. |
| 2024-02-29 | Dr. Nabel’s broad experience and expertise within the pharmaceutical and biotech industries, as well as his history of leadership within the National Institutes of Health, will provide the Board with valuable insights into many aspects of our business, including with respect to our science based and research and development programs. |
| 2025-03-14 | Dr. Nabel was appointed as Chief Innovation Officer of the Company and as a director... He served as Chief Scientific Officer, Global Research and Development, and Head of the North American Research & Development Hub at Sanofi. |
Data sourced from SEC filings. Last updated: 2025-10-11